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Abstract
Background: Studies show that patients make lifestyle changes soon after certain
solid tumor diagnoses, suggesting that this may be a teachable moment to motivate
and promote healthy behaviors. There is a paucity of data regarding changes made
after a diagnosis of a hematologic malignancy.
Methods: A cross-sectional study of 116 patients at a community oncology center
who completed anonymous questionnaires was performed. Questions addressed lifestyle choices made with respect to smoking, alcohol consumption, recreational drug
use, diet, and exercise habits before and after diagnosis of a hematologic malignancy.
Support systems utilized, including psychiatry services, were also assessed.
Results: Patients exhibited significant reduction in smoking behavior (Χ2 = 31.0,
p < 0.001). 82.4% (n = 14) of one pack per day smokers quit between the time periods, with nearly all smokers showing a reduction after diagnosis. Alcohol use overall
did not change significantly, however, 10.3% (n = 12) of patients reported quitting
drinking completely between time periods. Changes in dietary intake and exercise
were not statistically significant overall. Utilization of external support systems correlated with improved diet as well as decrease in total smoking years.
Conclusions: This study demonstrates that patients exhibited significant lifestyle
changes after being diagnosed with a hematologic malignancy. Clinicians should take
advantage of this ‘teachable moment’ to educate patients about positive health behavior changes. Advances in cancer therapeutics have led to an increase in cancer survivors, this education is crucial in reducing the risk of developing chronic comorbidities
as well as secondary malignancies.
KEYWORDS
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IN T RO D U C T IO N

With the advent of various effective and feasible treatment options for hematologic malignancies, survival rates and quality
of life have improved significantly over the last few decades.1
Cancer survivors have been shown to be at increased risk of
developing chronic comorbidities such as diabetes, obesity,
and cardiovascular disease.2 Metabolic syndrome associated
diseases, particularly obesity, have been associated with increased risk of developing secondary cancers (solid tumors
such as breast, colon, renal cell carcinoma, endometrial, adenocarcinoma of the esophagus).2 Lifestyle modifications
to change detrimental behaviors such as smoking, alcohol
consumption, unhealthy diets, and sedentary lifestyle among
individuals who have been diagnosed with cancer may help
to improve outcomes, or to reduce the incidence of developing negative health outcomes related to unhealthy lifestyle
behaviors. For example, healthier choices have the potential
to improve prognosis, reduce sequelae of cancer treatments,
lower risk of cancer recurrence, decrease incidence of a
second cancer, and/or reduce risk for chronic comorbidities
such as cardiovascular disease, diabetes, hypertension, and
obesity.2-4
Some studies show that cancer survivors make health
behavior changes (e.g., quitting smoking, improving diet
and exercise) soon after diagnosis or treatment, suggesting
that a cancer diagnosis may motivate and promote healthy
behaviors.3-9 The American Cancer Society (ACS) has published guidelines and principles regarding nutrition, physical
activity, and alcohol consumption. An ACS study of cancer
survivors has demonstrated that a cancer diagnosis could be
a “teachable moment” –an opportunity linking a health message to a presenting problem, regardless of the receptivity of
the patient.2
Strong support systems empower patients to cope with the
stress and anxiety of diagnosis and treatment. Patients who
demonstrated positive coping behaviors and those who perceived more social support were more likely to exhibit positive health behavior changes.10 This is evidenced by studies
reporting an association with higher risk health behaviors
in cancer survivors who had higher levels of life stressors.
Better outcomes were noted when patients took an active approach to coping strategies compared to those who took a
passive or indifferent stance.11
Much literature on understanding lifestyle changes comes
from studying female breast cancer survivors.7,8,12,13 Breast
cancer survivors have identified family, friends, support
groups, and spirituality as sources of social support, enabling
them to cope favorably with the negative physical and psychological aspects of breast cancer.8 A cross-sectional study
of breast cancer survivors also demonstrated a positive association between active coping strategies and improved diet
and exercise patterns.12
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There is, however, little information available regarding
lifestyle changes that patients make after being diagnosed
with a hematologic malignancy. The aim of our study was
to compare lifestyle modifications (with respect to smoking,
alcohol consumption, recreational drug use, diet, and exercise habits) in patients made before and after diagnosis of a
hematological malignancy. We also examined support systems utilized and barriers to change identified by our patient
population.
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M ETHODS

The survey instrument was developed based on the literature
studying lifestyle changes in female breast cancer survivors
and the authors’ clinical experience caring for patients with
hematologic malignancies. The questions addressed lifestyle
choices made with respect to smoking, alcohol consumption,
recreational drug use, diet, and exercise habits before and after
diagnosis of a hematologic malignancy. We also inquired
about patient demographics and support systems utilized,
including psychiatry/mental health services. Behavioral patterns were collected as number of days per week the patient
partook in the behavior. We measured fruit days per week as
the number of days per week the patient consumed at least
4–5 servings of fruit; cereal days per week as the number of
days per week the patient consumed at least six servings of
whole grain cereals; low-fat days as the number of days per
week the patient ingested two or fewer servings of fats and
oils; and exercise days as the number of days per week the
patient participated in at least 30 minutes of exercise/activity.
Two open ended questions were also included to understand
potential reasons underlying the lifestyle choices that were
made.
We surveyed adult patients with a diagnosis of a hematologic malignancy at a community oncology center. Adult
patients aged 18 and older with a diagnosis of a hematologic
malignancy (i.e., leukemia, lymphoma, or myeloma) either
currently undergoing treatment or having completed treatment were included. To assess any differences between patients treated for aggressive vs indolent malignancies, further
categorization was made. Patients with CLL, CML, and HCL
were grouped as indolent, patients with NHL, HL, and MM
as intermediate, and those with AML, ALL, T-cell leukemia,
and DLBCL as aggressive, The survey instrument also required patients to self-report their current treatment status
(ongoing, completed, or never requiring treatment). Patients
with multiple malignancies, incomplete surveys, and protected populations (such as pregnant or incarcerated patients)
were excluded.
Clinic staff provided survey forms to all patients who
were willing to participate in the study. Completed surveys
were returned by the patients in sealed envelopes which were
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immediately placed in a locked container to maintain anonymity. No protected health information was collected on the
surveys. Members of the research team reviewed and compiled data from the anonymous surveys.

|

2.1

Statistical methods

Data analyses were conducted for main effects of interest and
for subgroup analyses where appropriate. For comparisons of
continuous outcomes, data were first examined for normality using both the Shapiro-Wilk test and by examination of
measures of skewness and kurtosis. In this study, the data
met appropriate distributional assumptions, and therefore a
paired-samples t-test was used. Changes in categorical responses were analyzed using the McNemar-Bowker test with
exact p-values. All analyses were conducted using SPSS (v.
24).
This study was approved by the Institutional Review
Board of the University of Nevada School of Medicine, Las
Vegas (UNLV).
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TABLE 1

Demographic and study sample characteristics

Variable

Category

Frequency
(N)

Percent
(%)

Sex

Female

56

48.3

Male

60

51.5

African American

12

10.3

3

2.6

Caucasian

72

62.1

Hispanic

22

19.0

5

4.3

Race

Asian/PI

Other
Marital status

Employment

Unknown

2

1.7

Divorced

19

16.4

Married

66

56.9

With partner

3

2.6

Single/Never
Married

16

13.8

Widowed

12

10.3

Employed

44

37.9

Not employed

35

30.2

Retired

36

31.0

Unknown

R E S U LTS

Of the 139 patients who were approached, nine patients declined to participate in the study, 14 patients were excluded
due to incomplete surveys (n = 6) and a history of multiple
malignancies (n = 8), resulting in 116 completed surveys included for data analysis. Patient characteristics are described
in detail in Table 1.
Patients ranged in age from 19 to 89 years, with a median
age of 62 years (Mean = 60.3, SD = 15.51). Most patients
were Caucasian (62.1%, n = 72), married or with a partner
(59.5%, n = 69), and had a college or vocational degree
(63.8%, n = 74). Patients were relatively uniformly distributed in terms of employment status and income. Most patients had a diagnosis of lymphoma (52.6%, n = 61) and were
within 2–10 years since diagnosis (58.6%, n = 68). Regarding
prognosis, most patients were of intermediate cancer severity
(60.3%) with either a complete (44.0%) or current (45.7%)
treatment status (Table 1).

3.1 | Smoking, drug, and alcohol
use behavior
Smoking behaviors, as measured by packs per day,
changed significantly after a cancer diagnosis (Χ2 = 31.0,
p < 0.001). Most notably, zero nonsmokers initiated
smoking behavior after diagnosis, a large percentage
of smokers quit entirely (82.4%, n = 14, of 1–2 pack
per day smokers and 50%, n − 2, of >2 pack per day

Education

1

0.9

Less than HS

13

11.2

High school

28

24.1

College

52

44.8

Vocational

22

19.0

Unknown
Income

Diagnosis

1

0.9

<30 K

29

25

30–50 K

23

19.8

50–100 K

25

21.6

>100 K

14

12.1

Unknown

25

21.6

Leukemia

30

25.9

Lymphoma

61

52.6

Myeloma

25

21.6

Years

0–1

23

19.8

Since

2–10

68

58.6

Diagnosis

>10

25

21.6

Prognosis

Aggressive

18

15.5

Indolent

25

21.5

Intermediate

70

60.3

Not reported
Treatment status

3

2.6

Complete

51

44.0

Current

53

45.7

Never required

12

10.3

smokers), with nearly all participants who smoked at time
one (T1, before diagnosis) reducing their packs per day
smoked at time two (T2, after diagnosis). This reduction
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in smoking also resulted in a significant drop in the total
number of reported smoking years for patients between
T1 (mean = 20.77, SE = 2.494) and T2 (mean = 16.71,
SE = 2.652) resulting in a mean reduction of 4.1 years
(t = 2.436, p = 0.023). Alcohol use, measured as drinks
per week, did not change significantly (Χ2 = 10.6,
p = 0.102); however, it is notable that 10.3% (n = 12)
of patients reported quitting drinking completely between
time periods (Table 2). Results in drug and alcohol use as
reported above were similar between sexes.
Data were too sparse to test significant differences based
on cancer severity and treatment status, but some results
were interesting. One patient with aggressive cancer reported smoking >2 packs/day and continued to do so after
treatment, but nearly all of the other smokers reported decreases in packs per day at T2. Further, four patients went
from multiple drinks per week to 0 reported drinks per week
between time periods, and this occurred regardless of cancer severity. THC use mirrored that of the entire sample.

|
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Patterns were similar across variables for treatment status,
with general decreases between time periods. Interestingly,
even those who never received treatment reported smoking
cessation.

3.2

|

Diet and exercise

Changes in dietary intake and exercise were not consistent
between time periods. Mean fruit days per week increased
significantly between time periods (t = 3.100, p = 0.002).
This result was most notable for males (t = 3.845, p < 0.001),
those who reported being employed (t = 3.947, p < 0.001),
those 2–10 years post diagnosis (t = 3.204, p = 0.002),
those with curable cancers (t = 2.332, p = 0.025), and
those with lymphoma (t = 3.487, p = 0.001). This trend
was also true for those with intermediate cancers and those
who completed treatment, however was not statistically
significant.

T A B L E 2 Summary table of changes in drug and alcohol use between Time 1 (before diagnosis) and Time 2 (after diagnosis); percentages are
shown based on row totals (N)

Number of packs
a day

Change in behavior, cigarette packs per day at Time 2 for the
same patients compared to Time 1

Patients (N)
at Time 1

0

<1

1–2

>2

Χ2 statistic

p-value

0

71

71 (100%)

0 (0%)

0 (0%)

0 (0%)

31.0

<0.001

<1

21

14 (66.7%)

6 (28.6%)

1 (4.8%)

0 (0%)

1–2

17

14 (82.4%)

1 (5.9%)

2 (11.8%)

0 (0%)

>2

4

2 (50%)

0 (0%)

1 (25%)

1 (25%)

Smoking (cigarettes)

Number of
hits a day

Change in behavior, marijuana hits per day at Time 2 for the
same patients compared to Time 1

Patients (N)
at Time 1

0

109

109 (100%)

1–5

5–10

>10

Χ2 statistic

p-value

103.1

<0.001

Marijuana use
0
1–5

1

0 (0%)

0 (0%)

0 (0%)

0 (0%)

1 (100%)

0 (0%)

0 (0%)

5–10

2

0 (0%)

0 (0%)

2 (100%)

0 (0%)

>10

3

1 (33.3%)

0 (0%)

0 (0%)

2 (66.7%)

Number of
drinks per
day

Patients (N)
at Time 1

Change in behavior, alcoholic drinks per day at Time 2 for the same
patients compared to Time 1
0

<1

58 (95.1%)

0 (0%)

5–7

>7

Χ2 statistic

p-value

3 (4.9%)

0 (0%)

0 (0%)

10.6

0.102

1–5

Alcohol consumption
0

61

<1

1

0 (0%)

1 (100%)

0 (0%)

0 (0%)

0 (0%)

1–5

35

7 (20%)

0 (0%)

28 (80%)

0 (0%)

0 (0%)

5–7

10

1 (10%)

0 (0%)

1 (10%)

8 (80%)

0 (0%)

>7

9

4 (44.4%)

0 (0%)

2 (22.2%)

1 (11.1%)

2 (22.2%)
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T A B L E 3 Means and standard errors for Time 1 (before diagnosis) and Time 2 (after diagnosis) measurements for Diet and Exercise variables.
Paired t-tests with exact p-values are reported
Measure

Time 1

Time 2

Mean difference

t-statistic

p-value

4.15 (2.040)

−0.557

−3.100

0.002

Total sample
Fruit days

3.59 (2.090)

Cereal days

3.68 (2.286)

3.80 (2.154)

−0.114

−0.625

0.534

Fat days

3.46 (2.116)

3.25 (2.151)

0.209

1.468

0.145

Exercise days
Cumulative

3.00 (2.485)

2.92 (2.658)

0.079

0.361

0.719

13.43 (6.446)

14.14 (6.682)

−0.704

−1.260

0.210

3.56 (1.977)

4.44 (2.036)

−0.889

−1.978

0.064

Aggressive cancer
Fruit days
Cereal days

4.22 (1.896)

4.56 (1.977)

−0.333

−0.669

0.513

Fat days

3.00 (1.910)

3.17 (2.229)

−0.167

−0.402

0.692

Exercise days
Cumulative

2.76 (2.658)

2.41 (2.763)

0.353

0.636

0.534

13.39 (7.163)

14.44 (7.602)

−1.056

−0.629

0.538

3.71 (2.258)

3.68 (2.074)

0.036

0.099

0.922

Indolent cancer
Fruit days
Cereal days

3.59 (2.454)

3.67 (2.386)

−0.074

−0.189

0.852

Fat days

3.56 (2.172)

3.00 (2.166)

0.566

2.500

0.019

Exercise days
Cumulative

3.37 (2.388)

2.74 (2.379)

0.630

1.885

0.071

13.32 (6.549)

12.75 (6.287)

0.571

0.676

0.505

Intermediate cancer
Fruit days

3.55 (2.076)

4.26 (2.027)

−0.710

−3.088

0.003

Cereal days

3.58 (2.323)

3.65 (2.092)

−0.072

−0.317

0.752

Fat days

3.54 (2.158)

3.37 (2.148)

0.171

0.909

0.367

Exercise days

2.91 (2.501)

3.11 (2.748)

−0.200

−0.663

0.509

13.49 (6.307)

14.62 (6.607)

−1.130

−1.509

0.136

Cumulative
Treatment complete
Fruit days

3.38 (1.905)

4.10 (2.023)

−0.720

−2.599

0.012

Cereal days

3.50 (2.197)

3.66 (2.182)

−0.160

−0.610

0.545

Fat days

3.57 (2.229)

3.69 (2.214)

−0.118

−0.465

0.644

Exercise days

3.16 (2.502)

3.52 (2.735)

−0.360

−0.994

0.325

13.42 (6.834)

15.00 (7.332)

−1.580

−1.608

0.114

Cumulative
Treatment current
Fruit days

3.75 (2.227)

4.19 (2.039)

−0.434

−1.512

0.137

Cereal days

3.88 (2.315)

3.85 (2.052)

0.038

0.133

0.895

Fat days

3.33 (2.007)

2.88 (2.006)

0.442

2.599

0.012

Exercise days

2.77 (2.414)

2.23 (2.438)

0.538

1.678

0.099

13.49 (6.197)

13.19 (6.070)

0.302

0.404

0.688

Cumulative
Treatment never received
Fruit days

3.75 (2.301)

4.17 (2.290)

−0.417

−2.159

0.054

Cereal days

3.58 (2.644)

4.17 (2.588)

−0.583

−1.134

0.281

Fat days

3.58 (2.234)

3.00 (2.335)

0.583

1.735

0.111

Exercise days

3.33 (2.839)

3.42 (2.746)

−0.083

−1.000

0.339

Cumulative

13.25 (6.398)

14.75 (6.398)

−1.500

−1.807

0.098

Mean cereal days increased slightly, but not significantly,
from T1 to T2, whereas low fat diet consumption and exercise days slightly decreased from T1 to T2. Fat consumption

also decreased significantly for those with indolent cancers
(t = 2.500, p = 0.019), and those under current treatment
(t = 2.599, p = 0.012) (Table 3).
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3.3 | Psychiatric visits and external
support systems
Interestingly, only 19 patients (16.5%) reported seeing a
psychiatrist. Two of these patients reported seeking psychiatric support at T2 even though they did not have a history
of seeing a psychiatrist at T1. Of the 17 patients who sought
psychiatric treatment at T1, eight (47.1%) stopped seeing the
psychiatrist at T2, though this was not significant (exact binomial, p = 0.109).
Of further interest is that 50% of those with aggressive cancers reported using four or more support systems compared to
only 25% for indolent and 16% for intermediate cancers; also a
third of those who completed treatment also used four or more
support systems, compared to 17% and 8% for those currently
in treatment and those never receiving treatment, respectively.
The use of psychiatric treatment did not differ as a function of
cancer severity or treatment status (all p > 0.05).
Two open-dialog questions were included in our survey
addressing issues patients faced that were either beneficial or
detrimental to healthy living. These questions were included in
order to identify concepts that require further research. These
descriptive data were reviewed to identify common themes
expressed by patients. Many patients expressed a heightened
awareness of health after their cancer diagnosis. Patients frequently identified challenges such as advancing age, comorbidities (most common were diabetes, chronic pain, chronic
kidney disease), lack of familial support, fatigue, reduced appetite, anxiety, stress, and financial burden of healthy choices
(e.g., “healthy food is expensive, fast-food is cheaper and
more accessible”) as factors that prevented healthy lifestyle
changes. Recurring elements supporting positive change included maintaining a positive attitude, access to educational
material/physician counseling, personally researching healthful choices, having long-term goals, mindfulness, and strong
support from family, friends, and/or religion.

4
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D IS C U SS ION

Our study demonstrates patients with hematologic malignancies make positive lifestyle and behavior changes, most
notably by reducing or quitting smoking. Our findings are
comparable to other studies that have shown similar behavioral change patterns after receiving major diagnoses such as
cardiovascular disease or solid malignancies.14,15
There is a critical need to improve prevention and management of chronic comorbidities in the growing population
of cancer survivors. At the time of a serious diagnosis, patients experience an increased emotional state, during which
they often realize or better understand the impact of their
daily choices. It is in this period that patients are often more
open to a positive healthcare message and are more likely to
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implement major lifestyle changes. It is important that providers are aware of this opportunity and utilize it to motivate
patients to adopt or improve healthy behavior and lifestyle
choices.2,15 Understanding the rationale behind positive and
negative changes made by these patients is of great importance as this will enable healthcare staff to identify factors
that facilitate or impede positive change. A collaborative
model integrating technology to deliver behavioral interventions along with routine survivorship services has been suggested to manage healthcare promotion and care coordination
between the primary care provider and specialist.16
Our patients identified common themes such as current
health status, treatment side effects, social support, finances,
motivation, and access to education/research materials as
among factors influencing health behavior change. Similar
attitudes and challenges have been identified in other patient
populations including endometrial cancer survivors17 and
adolescent/young adult cancer survivors.18 Breast cancer patients who felt that they had control over their health tended
to improve diet and exercise habits.13
Diagnostic interviews and self-report instruments have
revealed high prevalence of depression and psychosocial
distress in cancer patients.19 The SMaRT Oncology-2 trial
showed that a collaborative treatment approach for major
depression in cancer patients with the assistance of psychiatrists, primary care physicians, and nurses resulted in reduced
depression, anxiety, fatigue, pain, improved quality of life,
overall functioning, and health.20 We observed that only a
small number of patients in our study utilized the assistance of
mental health services. Improving screening for depression at
clinic visits and counseling patients regarding the availability
and benefit of these services may help to alleviate an unmet
need. In addition to psychiatric visits, external support systems may be important for lifestyle changes in these patients.
Patients who perceived having more social support were better able to cope with the stresses of a cancer diagnosis and
treatment, and were more likely to make positive health behavior changes.10 Though sample sizes are often small when
doing subanalyses, our study suggests that having external
support systems is related to decreased total smoking years
(1–3 support systems mean difference = 3.816, t = 2.199,
p = 0.041) and increased fruit days per week (1–3 support
systems mean difference = −0.537, t = −2.507, p = 0.014;
4+ support systems mean difference = −0.963, t = −2.871,
p = 0.008).
We recognize there are some limitations to this study.
Some degree of recall bias is anticipated; patients may
overestimate the extent of lifestyle modifications made,
and may not be entirely truthful about the magnitude of
changes implemented. Our sample size was not large
enough to perform detailed subgroup analyses. We also did
not assess the true impact of the teachable moment on our
patients as we did not survey how they were counseled on
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behavioral modifications at the time of diagnosis. It is also
possible that some long-term survivors may have made
short-lived changes initially that were not sustained and
therefore not captured.
Future directions: The initial results of this study serve
to generate hypotheses for future research and to underscore
the importance of assessing lifestyle behaviors as a critical
component of holistic cancer treatment. Providing patients
with adequate advice and strong support regarding lifestyle
modification, taking advantage of the “teachable moment”,
along with close follow-up at regular intervals to ensure that
the positive behaviors are sustained, is of utmost importance.
This multidimensional support will ultimately improve the
well-being and quality of life of patients with hematologic malignancies and decrease the burden of chronic comorbidities.
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